Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Бібліографічні деталі
Автори:	Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
Формат:	Journal article
Мова:	English
Опубліковано:	Wiley 2021

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
за авторством: Xu, S, та інші
Опубліковано: (2019)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
за авторством: Wamil, M, та інші
Опубліковано: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
за авторством: Leal, J, та інші
Опубліковано: (2022)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
за авторством: Califf, R, та інші
Опубліковано: (2003)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
за авторством: Currie, G, та інші
Опубліковано: (2017)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
за авторством: Liam Mc Morrow, та інші
Опубліковано: (2024-02-01)

Impaired glucose tolerance: who and how treats it?
за авторством: M. N. Mamedov
Опубліковано: (2005-12-01)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
за авторством: Holman, R, та інші
Опубліковано: (2017)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
за авторством: Yates, T, та інші
Опубліковано: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
за авторством: Yates, T, та інші
Опубліковано: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
за авторством: Wamil, M, та інші
Опубліковано: (2021)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
за авторством: Susanne Andersson, та інші
Опубліковано: (2011-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
за авторством: Nihar Ranjan Mohanty, та інші
Опубліковано: (2022-06-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
за авторством: Wamil, M, та інші
Опубліковано: (2020)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
за авторством: Farrer, M, та інші
Опубліковано: (1993)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
за авторством: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Опубліковано: (2012-01-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
за авторством: Preiss, D, та інші
Опубліковано: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
за авторством: Califf, R, та інші
Опубліковано: (2008)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
за авторством: Holman, R
Опубліковано: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
за авторством: Yutaka Inoue, та інші
Опубліковано: (2022-06-01)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
за авторством: Page, R, та інші
Опубліковано: (1993)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
за авторством: Ursula Mager, та інші
Опубліковано: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
за авторством: Xin Zhang, та інші
Опубліковано: (2023-01-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
за авторством: Anke Tönjes, та інші
Опубліковано: (2010-01-01)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
за авторством: Huibin Huang, та інші
Опубліковано: (2013-01-01)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
за авторством: Gerstein, H, та інші
Опубліковано: (2006)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
за авторством: Preiss, D, та інші
Опубліковано: (2012)

Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis
за авторством: Zhen Yang, та інші
Опубліковано: (2017-09-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
за авторством: Dos Santos, M, та інші
Опубліковано: (2017)

Impaired glucose tolerance in sleep disorders.
за авторством: Marietta Keckeis, та інші
Опубліковано: (2010-03-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
за авторством: Stevens, R, та інші
Опубліковано: (2005)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
за авторством: Brkić Milena, та інші
Опубліковано: (2022-01-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
за авторством: Yupu Liu, та інші
Опубліковано: (2022-02-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
за авторством: Mostafa, SA, та інші
Опубліковано: (2017)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
за авторством: Mc Morrow, L, та інші
Опубліковано: (2018)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
за авторством: Lu Yu, та інші
Опубліковано: (2022-06-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
за авторством: Marilia Harumi Higuchi dos Santos, та інші
Опубліковано: (2017-01-01)

List of people who have paid
за авторством: Cork County Association, CCA

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
за авторством: Latini, R, та інші
Опубліковано: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
за авторством: Sharma, A, та інші
Опубліковано: (2016)

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Схожі ресурси

Схожі ресурси